

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein activation cascade (GO:0072376) | 9.19648334 |
| 2 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 8.77340760 |
| 3 | Fc-gamma receptor signaling pathway (GO:0038094) | 8.77340760 |
| 4 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 8.77340760 |
| 5 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 8.65445752 |
| 6 | negative regulation of B cell proliferation (GO:0030889) | 8.18288607 |
| 7 | retina homeostasis (GO:0001895) | 7.78896813 |
| 8 | humoral immune response (GO:0006959) | 7.28866847 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.68301874 |
| 10 | B cell receptor signaling pathway (GO:0050853) | 6.44298383 |
| 11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.24779759 |
| 12 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.24779759 |
| 13 | positive regulation of B cell differentiation (GO:0045579) | 6.23908985 |
| 14 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 5.55299046 |
| 15 | regulation of B cell differentiation (GO:0045577) | 5.46437123 |
| 16 | regulation of B cell proliferation (GO:0030888) | 5.40417633 |
| 17 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 5.27907648 |
| 18 | negative regulation of glucose import (GO:0046325) | 5.11842841 |
| 19 | cellular response to zinc ion (GO:0071294) | 4.60644130 |
| 20 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.57790497 |
| 21 | positive regulation of Rho protein signal transduction (GO:0035025) | 4.56113239 |
| 22 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.55236056 |
| 23 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 4.45212756 |
| 24 | negative regulation of B cell activation (GO:0050869) | 4.32271795 |
| 25 | signal peptide processing (GO:0006465) | 4.22323422 |
| 26 | negative regulation of glucose transport (GO:0010829) | 4.21962825 |
| 27 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.21846183 |
| 28 | fucose catabolic process (GO:0019317) | 4.10154050 |
| 29 | L-fucose metabolic process (GO:0042354) | 4.10154050 |
| 30 | L-fucose catabolic process (GO:0042355) | 4.10154050 |
| 31 | B cell proliferation (GO:0042100) | 4.09240859 |
| 32 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.07923540 |
| 33 | mature B cell differentiation (GO:0002335) | 3.85072435 |
| 34 | regulation of B cell activation (GO:0050864) | 3.74238185 |
| 35 | Fc receptor signaling pathway (GO:0038093) | 3.72230659 |
| 36 | immune response-activating signal transduction (GO:0002757) | 3.71169309 |
| 37 | immune response-regulating cell surface receptor signaling pathway (GO:0002768) | 3.70293886 |
| 38 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.64440611 |
| 39 | Fc-epsilon receptor signaling pathway (GO:0038095) | 3.64369743 |
| 40 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.61802593 |
| 41 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 3.59916742 |
| 42 | positive regulation of Rap GTPase activity (GO:0032854) | 3.57002773 |
| 43 | positive regulation of immunoglobulin production (GO:0002639) | 3.56387599 |
| 44 | intestinal epithelial cell development (GO:0060576) | 3.47565137 |
| 45 | maternal placenta development (GO:0001893) | 3.47219352 |
| 46 | negative thymic T cell selection (GO:0045060) | 3.47197234 |
| 47 | regulation of B cell apoptotic process (GO:0002902) | 3.46267814 |
| 48 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.39466628 |
| 49 | negative regulation of osteoclast differentiation (GO:0045671) | 3.33152966 |
| 50 | activation of immune response (GO:0002253) | 3.33051968 |
| 51 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.31764428 |
| 52 | regulation of regulatory T cell differentiation (GO:0045589) | 3.28559848 |
| 53 | antibacterial humoral response (GO:0019731) | 3.27873584 |
| 54 | antimicrobial humoral response (GO:0019730) | 3.25494942 |
| 55 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.23131393 |
| 56 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 3.21428505 |
| 57 | response to interleukin-15 (GO:0070672) | 3.20637098 |
| 58 | regulation of gamma-delta T cell activation (GO:0046643) | 3.19764772 |
| 59 | negative T cell selection (GO:0043383) | 3.19478471 |
| 60 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.09707373 |
| 61 | positive thymic T cell selection (GO:0045059) | 3.09683864 |
| 62 | thymic T cell selection (GO:0045061) | 3.07672132 |
| 63 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.04936483 |
| 64 | regulation of immunoglobulin production (GO:0002637) | 3.04825821 |
| 65 | bone resorption (GO:0045453) | 3.04761454 |
| 66 | positive regulation of nuclease activity (GO:0032075) | 3.03731110 |
| 67 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.01860476 |
| 68 | B cell homeostasis (GO:0001782) | 3.01622166 |
| 69 | peptidyl-asparagine modification (GO:0018196) | 2.99389917 |
| 70 | cytidine metabolic process (GO:0046087) | 2.99241865 |
| 71 | cytidine catabolic process (GO:0006216) | 2.99241865 |
| 72 | cytidine deamination (GO:0009972) | 2.99241865 |
| 73 | regulation of Rap GTPase activity (GO:0032317) | 2.98949129 |
| 74 | regulation of interferon-alpha production (GO:0032647) | 2.97492239 |
| 75 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.96898005 |
| 76 | mature B cell differentiation involved in immune response (GO:0002313) | 2.96595631 |
| 77 | N-acetylneuraminate metabolic process (GO:0006054) | 2.96572315 |
| 78 | positive regulation of B cell activation (GO:0050871) | 2.94311017 |
| 79 | negative regulation of cell killing (GO:0031342) | 2.94193167 |
| 80 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.94193167 |
| 81 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.94044714 |
| 82 | regulation of nuclease activity (GO:0032069) | 2.92658320 |
| 83 | T cell selection (GO:0045058) | 2.92637803 |
| 84 | serine transport (GO:0032329) | 2.92269848 |
| 85 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.91942511 |
| 86 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.90269830 |
| 87 | B cell activation (GO:0042113) | 2.90180233 |
| 88 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.89594595 |
| 89 | lymphocyte costimulation (GO:0031294) | 2.88340291 |
| 90 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.85888227 |
| 91 | T cell costimulation (GO:0031295) | 2.85300829 |
| 92 | mannose metabolic process (GO:0006013) | 2.84214989 |
| 93 | cellular response to unfolded protein (GO:0034620) | 2.79898467 |
| 94 | negative regulation of mononuclear cell proliferation (GO:0032945) | 2.77944291 |
| 95 | negative regulation of lymphocyte proliferation (GO:0050672) | 2.77944291 |
| 96 | protein N-linked glycosylation (GO:0006487) | 2.77623805 |
| 97 | Golgi transport vesicle coating (GO:0048200) | 2.74372373 |
| 98 | COPI coating of Golgi vesicle (GO:0048205) | 2.74372373 |
| 99 | complement activation, classical pathway (GO:0006958) | 18.7061131 |
| 100 | complement activation (GO:0006956) | 14.3049158 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.65970035 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.52756344 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.65095509 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.52721247 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 4.37297912 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.75930558 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.61708627 |
| 8 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.57329083 |
| 9 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.49933976 |
| 10 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.41250745 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.20776841 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.17049610 |
| 13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.99910033 |
| 14 | MAF_26560356_Chip-Seq_TH1_Human | 2.83501639 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.83094084 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.81948830 |
| 17 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.75497635 |
| 18 | MYB_26560356_Chip-Seq_TH2_Human | 2.71495020 |
| 19 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.68486137 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.59724945 |
| 21 | MYB_26560356_Chip-Seq_TH1_Human | 2.59448008 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.35333714 |
| 23 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.24494715 |
| 24 | GATA1_22025678_ChIP-Seq_K562_Human | 2.21046741 |
| 25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.20161556 |
| 26 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.18834658 |
| 27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.17970518 |
| 28 | UTX_26944678_Chip-Seq_JUKART_Human | 2.15515546 |
| 29 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.07095071 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.97362135 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.97064746 |
| 32 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.96361144 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.91950489 |
| 34 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.82954157 |
| 35 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.78745715 |
| 36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.76929551 |
| 37 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.75881642 |
| 38 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.70920827 |
| 39 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.69860034 |
| 40 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.60201730 |
| 41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.59382483 |
| 42 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.59379381 |
| 43 | MAF_26560356_Chip-Seq_TH2_Human | 1.51697895 |
| 44 | GATA3_26560356_Chip-Seq_TH2_Human | 1.48148781 |
| 45 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.46761956 |
| 46 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.46005408 |
| 47 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.45071747 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.44737375 |
| 49 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.39851756 |
| 50 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38255597 |
| 51 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.31658612 |
| 52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.31510764 |
| 53 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.29756933 |
| 54 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.28880700 |
| 55 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.27169855 |
| 56 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22155167 |
| 57 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.21577137 |
| 58 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.21507597 |
| 59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.21350495 |
| 60 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.06431990 |
| 61 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06363021 |
| 62 | GATA1_19941826_ChIP-Seq_K562_Human | 1.02333918 |
| 63 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.02039567 |
| 64 | GATA2_19941826_ChIP-Seq_K562_Human | 1.00547432 |
| 65 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99876338 |
| 66 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99459228 |
| 67 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.91198238 |
| 68 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.90254762 |
| 69 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.89080239 |
| 70 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87546898 |
| 71 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.85657380 |
| 72 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85240705 |
| 73 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.84813344 |
| 74 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83570902 |
| 75 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.83504083 |
| 76 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.83361471 |
| 77 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83256817 |
| 78 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.82183241 |
| 79 | GATA3_26560356_Chip-Seq_TH1_Human | 0.81950826 |
| 80 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.81554641 |
| 81 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.80391967 |
| 82 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.79829672 |
| 83 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.78889826 |
| 84 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.78596787 |
| 85 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77618989 |
| 86 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77445366 |
| 87 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.77242096 |
| 88 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.76859581 |
| 89 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.76828699 |
| 90 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.76457176 |
| 91 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.74891791 |
| 92 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.74432149 |
| 93 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.73850411 |
| 94 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72564107 |
| 95 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.72336960 |
| 96 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.71147097 |
| 97 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.70931878 |
| 98 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70803504 |
| 99 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.70784120 |
| 100 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.70755210 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 5.72145910 |
| 2 | MP0001835_abnormal_antigen_presentation | 5.26979616 |
| 3 | MP0001800_abnormal_humoral_immune | 4.70510563 |
| 4 | MP0005387_immune_system_phenotype | 3.94261405 |
| 5 | MP0001790_abnormal_immune_system | 3.94261405 |
| 6 | MP0005671_abnormal_response_to | 3.52474820 |
| 7 | MP0003300_gastrointestinal_ulcer | 3.50104286 |
| 8 | MP0002452_abnormal_antigen_presenting | 3.43420073 |
| 9 | MP0002723_abnormal_immune_serum | 2.90622981 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.78848011 |
| 11 | MP0002420_abnormal_adaptive_immunity | 2.76291185 |
| 12 | MP0001819_abnormal_immune_cell | 2.71014789 |
| 13 | MP0001873_stomach_inflammation | 2.68851380 |
| 14 | MP0002398_abnormal_bone_marrow | 2.63289227 |
| 15 | MP0000716_abnormal_immune_system | 2.52037330 |
| 16 | MP0000685_abnormal_immune_system | 2.51088339 |
| 17 | MP0000689_abnormal_spleen_morphology | 2.23407432 |
| 18 | MP0002166_altered_tumor_susceptibility | 2.20824271 |
| 19 | MP0005025_abnormal_response_to | 2.19263001 |
| 20 | MP0003763_abnormal_thymus_physiology | 2.13666393 |
| 21 | MP0002429_abnormal_blood_cell | 2.04078704 |
| 22 | MP0001879_abnormal_lymphatic_vessel | 2.04020648 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 2.03430305 |
| 24 | MP0003436_decreased_susceptibility_to | 1.99839146 |
| 25 | MP0010234_abnormal_vibrissa_follicle | 1.98288875 |
| 26 | MP0010155_abnormal_intestine_physiology | 1.98287688 |
| 27 | MP0006054_spinal_hemorrhage | 1.97151645 |
| 28 | MP0004264_abnormal_extraembryonic_tissu | 1.92325288 |
| 29 | MP0002722_abnormal_immune_system | 1.88559067 |
| 30 | MP0004947_skin_inflammation | 1.83712619 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.80168200 |
| 32 | MP0002419_abnormal_innate_immunity | 1.79321408 |
| 33 | MP0005310_abnormal_salivary_gland | 1.73109816 |
| 34 | MP0001853_heart_inflammation | 1.67728682 |
| 35 | MP0009333_abnormal_splenocyte_physiolog | 1.67136004 |
| 36 | MP0002006_tumorigenesis | 1.62652302 |
| 37 | MP0002405_respiratory_system_inflammati | 1.56756463 |
| 38 | MP0000465_gastrointestinal_hemorrhage | 1.55484683 |
| 39 | MP0002396_abnormal_hematopoietic_system | 1.54586220 |
| 40 | MP0002933_joint_inflammation | 1.48975214 |
| 41 | MP0009785_altered_susceptibility_to | 1.44108084 |
| 42 | MP0004510_myositis | 1.35302843 |
| 43 | MP0001663_abnormal_digestive_system | 1.32887307 |
| 44 | MP0000703_abnormal_thymus_morphology | 1.32538356 |
| 45 | MP0003866_abnormal_defecation | 1.31883050 |
| 46 | MP0006082_CNS_inflammation | 1.27900810 |
| 47 | MP0000490_abnormal_crypts_of | 1.24635012 |
| 48 | MP0010352_gastrointestinal_tract_polyps | 1.23841560 |
| 49 | MP0003045_fibrosis | 1.15465277 |
| 50 | MP0005360_urolithiasis | 1.04934540 |
| 51 | MP0005076_abnormal_cell_differentiation | 1.03950053 |
| 52 | MP0004808_abnormal_hematopoietic_stem | 1.03366671 |
| 53 | MP0005464_abnormal_platelet_physiology | 1.01956382 |
| 54 | MP0001919_abnormal_reproductive_system | 1.00313097 |
| 55 | MP0002019_abnormal_tumor_incidence | 1.00090647 |
| 56 | MP0008872_abnormal_physiological_respon | 0.98239829 |
| 57 | MP0003183_abnormal_peptide_metabolism | 0.97633677 |
| 58 | MP0001533_abnormal_skeleton_physiology | 0.91501979 |
| 59 | MP0002136_abnormal_kidney_physiology | 0.89700795 |
| 60 | MP0008469_abnormal_protein_level | 0.87864691 |
| 61 | MP0005381_digestive/alimentary_phenotyp | 0.85743154 |
| 62 | MP0001348_abnormal_lacrimal_gland | 0.80495649 |
| 63 | MP0003075_altered_response_to | 0.78111139 |
| 64 | MP0002139_abnormal_hepatobiliary_system | 0.76439222 |
| 65 | MP0002693_abnormal_pancreas_physiology | 0.73201746 |
| 66 | MP0000477_abnormal_intestine_morphology | 0.72808311 |
| 67 | MP0000609_abnormal_liver_physiology | 0.71197372 |
| 68 | MP0008961_abnormal_basal_metabolism | 0.68895654 |
| 69 | MP0000733_abnormal_muscle_development | 0.67981460 |
| 70 | MP0008569_lethality_at_weaning | 0.67884576 |
| 71 | MP0005023_abnormal_wound_healing | 0.66180444 |
| 72 | MP0002998_abnormal_bone_remodeling | 0.65465508 |
| 73 | MP0003566_abnormal_cell_adhesion | 0.64583098 |
| 74 | MP0001545_abnormal_hematopoietic_system | 0.64389036 |
| 75 | MP0005397_hematopoietic_system_phenotyp | 0.64389036 |
| 76 | MP0000003_abnormal_adipose_tissue | 0.63472365 |
| 77 | MP0000013_abnormal_adipose_tissue | 0.63431700 |
| 78 | MP0003724_increased_susceptibility_to | 0.63218083 |
| 79 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.62476068 |
| 80 | MP0009278_abnormal_bone_marrow | 0.62400634 |
| 81 | MP0001666_abnormal_nutrient_absorption | 0.61378718 |
| 82 | MP0000920_abnormal_myelination | 0.60524713 |
| 83 | MP0008873_increased_physiological_sensi | 0.60143296 |
| 84 | MP0001881_abnormal_mammary_gland | 0.59657488 |
| 85 | MP0003656_abnormal_erythrocyte_physiolo | 0.58679463 |
| 86 | MP0001191_abnormal_skin_condition | 0.56392705 |
| 87 | MP0008057_abnormal_DNA_replication | 0.56323814 |
| 88 | MP0009643_abnormal_urine_homeostasis | 0.55719774 |
| 89 | MP0002254_reproductive_system_inflammat | 0.55596575 |
| 90 | MP0008874_decreased_physiological_sensi | 0.54770444 |
| 91 | MP0009763_increased_sensitivity_to | 0.54418571 |
| 92 | MP0002168_other_aberrant_phenotype | 0.54412965 |
| 93 | MP0003091_abnormal_cell_migration | 0.52694436 |
| 94 | MP0002083_premature_death | 0.52574550 |
| 95 | MP0002133_abnormal_respiratory_system | 0.51983341 |
| 96 | MP0005388_respiratory_system_phenotype | 0.51983341 |
| 97 | MP0005058_abnormal_lysosome_morphology | 0.50537774 |
| 98 | MP0003795_abnormal_bone_structure | 0.50458095 |
| 99 | MP0002009_preneoplasia | 0.49277241 |
| 100 | MP0000249_abnormal_blood_vessel | 0.48904909 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 9.30320592 |
| 2 | B lymphocytopenia (HP:0010976) | 8.07110480 |
| 3 | Abnormality of B cell number (HP:0010975) | 8.07110480 |
| 4 | Colitis (HP:0002583) | 7.17044387 |
| 5 | Recurrent sinusitis (HP:0011108) | 6.85386865 |
| 6 | Recurrent bronchitis (HP:0002837) | 6.39793993 |
| 7 | Cellulitis (HP:0100658) | 6.28825474 |
| 8 | Papilloma (HP:0012740) | 5.80683223 |
| 9 | Verrucae (HP:0200043) | 5.80683223 |
| 10 | Gastrointestinal stroma tumor (HP:0100723) | 5.65182520 |
| 11 | Recurrent viral infections (HP:0004429) | 5.56146350 |
| 12 | Inflammation of the large intestine (HP:0002037) | 5.52368629 |
| 13 | IgM deficiency (HP:0002850) | 5.39832334 |
| 14 | Gastrointestinal inflammation (HP:0004386) | 5.31094624 |
| 15 | Meningitis (HP:0001287) | 5.27834961 |
| 16 | Recurrent pneumonia (HP:0006532) | 4.51829559 |
| 17 | Chronic otitis media (HP:0000389) | 4.26802936 |
| 18 | Chronic sinusitis (HP:0011109) | 3.90091425 |
| 19 | Osteomyelitis (HP:0002754) | 3.86704788 |
| 20 | Recurrent lower respiratory tract infections (HP:0002783) | 3.83167876 |
| 21 | Vasculitis (HP:0002633) | 3.81408055 |
| 22 | Panhypogammaglobulinemia (HP:0003139) | 3.78784421 |
| 23 | Recurrent otitis media (HP:0000403) | 3.66486565 |
| 24 | Emphysema (HP:0002097) | 3.65336082 |
| 25 | Bronchitis (HP:0012387) | 3.60794068 |
| 26 | IgA deficiency (HP:0002720) | 3.47452472 |
| 27 | Thyroiditis (HP:0100646) | 3.30997775 |
| 28 | Restrictive lung disease (HP:0002091) | 3.27614885 |
| 29 | Sepsis (HP:0100806) | 3.24988078 |
| 30 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.22584199 |
| 31 | IgG deficiency (HP:0004315) | 3.17466088 |
| 32 | Skin rash (HP:0000988) | 3.12257272 |
| 33 | Pulmonary infiltrates (HP:0002113) | 3.12113553 |
| 34 | Lymphopenia (HP:0001888) | 3.11572610 |
| 35 | Abnormality of T cell physiology (HP:0011840) | 3.11160848 |
| 36 | Recurrent fungal infections (HP:0002841) | 3.03256456 |
| 37 | Myositis (HP:0100614) | 3.01739027 |
| 38 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.97805300 |
| 39 | Retrobulbar optic neuritis (HP:0100654) | 2.82946937 |
| 40 | Optic neuritis (HP:0100653) | 2.82946937 |
| 41 | Abnormality of T cells (HP:0002843) | 2.82348215 |
| 42 | Interstitial pulmonary disease (HP:0006530) | 2.65710793 |
| 43 | Nasal polyposis (HP:0100582) | 2.61208493 |
| 44 | Recurrent abscess formation (HP:0002722) | 2.60138453 |
| 45 | Recurrent bacterial skin infections (HP:0005406) | 2.56901621 |
| 46 | Abnormality of T cell number (HP:0011839) | 2.56702751 |
| 47 | T lymphocytopenia (HP:0005403) | 2.56415797 |
| 48 | Orchitis (HP:0100796) | 2.43149332 |
| 49 | Obstructive lung disease (HP:0006536) | 2.42910825 |
| 50 | Chronic obstructive pulmonary disease (HP:0006510) | 2.42910825 |
| 51 | Eczematoid dermatitis (HP:0000976) | 2.33136636 |
| 52 | Recurrent skin infections (HP:0001581) | 2.30244000 |
| 53 | Skin ulcer (HP:0200042) | 2.29402541 |
| 54 | Mitral stenosis (HP:0001718) | 2.27979400 |
| 55 | Pulmonary embolism (HP:0002204) | 2.26553441 |
| 56 | Small epiphyses (HP:0010585) | 2.25230663 |
| 57 | Keratoconjunctivitis sicca (HP:0001097) | 2.24333960 |
| 58 | Bronchiectasis (HP:0002110) | 2.21656731 |
| 59 | Increased IgE level (HP:0003212) | 2.21036028 |
| 60 | Abnormality of the nasal mucosa (HP:0000433) | 2.19534540 |
| 61 | Encephalitis (HP:0002383) | 2.17923233 |
| 62 | Recurrent cutaneous fungal infections (HP:0011370) | 2.16648999 |
| 63 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.16648999 |
| 64 | Chest pain (HP:0100749) | 2.15994971 |
| 65 | Hemoptysis (HP:0002105) | 2.15036789 |
| 66 | Keratoconjunctivitis (HP:0001096) | 2.13857444 |
| 67 | Arterial thrombosis (HP:0004420) | 2.13198543 |
| 68 | Mediastinal lymphadenopathy (HP:0100721) | 2.12217199 |
| 69 | Neutropenia (HP:0001875) | 2.07611592 |
| 70 | Viral hepatitis (HP:0006562) | 2.04155192 |
| 71 | Abnormality of the prostate (HP:0008775) | 2.02955605 |
| 72 | Autoimmune thrombocytopenia (HP:0001973) | 2.02478452 |
| 73 | Combined immunodeficiency (HP:0005387) | 2.02055179 |
| 74 | Arthralgia (HP:0002829) | 2.00976404 |
| 75 | Severe combined immunodeficiency (HP:0004430) | 1.97224728 |
| 76 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.95122688 |
| 77 | Lymphoma (HP:0002665) | 1.89613817 |
| 78 | Thrombocytosis (HP:0001894) | 1.89593617 |
| 79 | Gangrene (HP:0100758) | 1.86243556 |
| 80 | Leukopenia (HP:0001882) | 1.85437234 |
| 81 | Abnormality of the fingertips (HP:0001211) | 1.83845008 |
| 82 | Ureteral stenosis (HP:0000071) | 1.82606129 |
| 83 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.67099232 |
| 84 | Pustule (HP:0200039) | 1.66363055 |
| 85 | Dehydration (HP:0001944) | 1.64845720 |
| 86 | Gastrointestinal infarctions (HP:0005244) | 1.63835406 |
| 87 | Hypoplasia of the thymus (HP:0000778) | 1.62067676 |
| 88 | Acrocyanosis (HP:0001063) | 1.61731755 |
| 89 | Ureteral obstruction (HP:0006000) | 1.61237248 |
| 90 | Spontaneous hematomas (HP:0007420) | 1.61178785 |
| 91 | Fatigue (HP:0012378) | 1.60805626 |
| 92 | Thrombophlebitis (HP:0004418) | 1.57480701 |
| 93 | Abnormal foot bone ossification (HP:0010675) | 1.56540960 |
| 94 | Macroorchidism (HP:0000053) | 1.54722454 |
| 95 | Polyneuropathy (HP:0001271) | 1.53841842 |
| 96 | Flattened epiphyses (HP:0003071) | 1.52816693 |
| 97 | Vacuolated lymphocytes (HP:0001922) | 1.51955597 |
| 98 | Eosinophilia (HP:0001880) | 1.51458887 |
| 99 | Papilledema (HP:0001085) | 1.48615766 |
| 100 | Mucosal telangiectasiae (HP:0100579) | 1.47824304 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 6.16147214 |
| 2 | MAP4K1 | 5.57926368 |
| 3 | TXK | 3.42295801 |
| 4 | TAOK3 | 3.04413620 |
| 5 | GRK6 | 3.02619130 |
| 6 | RIPK4 | 2.77301324 |
| 7 | MAP3K10 | 2.76052430 |
| 8 | TYK2 | 2.72250949 |
| 9 | SYK | 2.50343247 |
| 10 | BLK | 2.23995572 |
| 11 | CSF1R | 2.23188496 |
| 12 | SIK2 | 2.13924544 |
| 13 | JAK1 | 2.01280603 |
| 14 | MAP3K14 | 2.00999116 |
| 15 | KIT | 1.99299380 |
| 16 | BTK | 1.81895375 |
| 17 | ITK | 1.58815511 |
| 18 | JAK3 | 1.52049776 |
| 19 | STK10 | 1.46033460 |
| 20 | TBK1 | 1.40768494 |
| 21 | FGFR3 | 1.40026430 |
| 22 | MAP3K13 | 1.39472386 |
| 23 | NME2 | 1.39144008 |
| 24 | PRKCH | 1.38379324 |
| 25 | IRAK4 | 1.36438772 |
| 26 | IRAK3 | 1.34555417 |
| 27 | EIF2AK3 | 1.33026315 |
| 28 | LRRK2 | 1.31041866 |
| 29 | FGFR4 | 1.30450652 |
| 30 | LYN | 1.28619588 |
| 31 | HCK | 1.26653258 |
| 32 | HIPK2 | 1.24433511 |
| 33 | IKBKE | 1.21269685 |
| 34 | IKBKB | 1.09721224 |
| 35 | EEF2K | 1.04713632 |
| 36 | PRKCQ | 1.04596585 |
| 37 | LCK | 1.01560888 |
| 38 | FES | 0.99259530 |
| 39 | PIM1 | 0.98661034 |
| 40 | CDK12 | 0.98139273 |
| 41 | MST4 | 0.95817771 |
| 42 | PIK3CG | 0.94644283 |
| 43 | TEC | 0.94551592 |
| 44 | FRK | 0.91178358 |
| 45 | ALK | 0.90977205 |
| 46 | TGFBR2 | 0.89672812 |
| 47 | SIK1 | 0.89112986 |
| 48 | NEK9 | 0.85753812 |
| 49 | JAK2 | 0.84142836 |
| 50 | CSK | 0.82510951 |
| 51 | BMPR2 | 0.82361623 |
| 52 | NEK2 | 0.79348262 |
| 53 | TRIB3 | 0.78281401 |
| 54 | EPHB1 | 0.70240985 |
| 55 | PDK1 | 0.66465056 |
| 56 | LMTK2 | 0.66459302 |
| 57 | CLK1 | 0.66255985 |
| 58 | MAPK7 | 0.64766196 |
| 59 | BMX | 0.64618495 |
| 60 | FYN | 0.60333661 |
| 61 | PRKD1 | 0.58899119 |
| 62 | MARK3 | 0.57273505 |
| 63 | MAP3K9 | 0.56247311 |
| 64 | ZAP70 | 0.53800657 |
| 65 | MAP3K7 | 0.49806488 |
| 66 | CDK4 | 0.49343067 |
| 67 | MATK | 0.48257267 |
| 68 | CHUK | 0.47328530 |
| 69 | CDK9 | 0.46164393 |
| 70 | MAPK4 | 0.43498799 |
| 71 | CDK6 | 0.42566381 |
| 72 | SIK3 | 0.42101044 |
| 73 | KSR2 | 0.41808176 |
| 74 | PRKD2 | 0.41235695 |
| 75 | NUAK1 | 0.40760620 |
| 76 | MAPK11 | 0.40563973 |
| 77 | PTK6 | 0.38688164 |
| 78 | ABL1 | 0.38117281 |
| 79 | MAPK12 | 0.34914255 |
| 80 | INSR | 0.34510481 |
| 81 | PKN2 | 0.33743376 |
| 82 | PRKCD | 0.33615312 |
| 83 | SGK3 | 0.31639429 |
| 84 | BRD4 | 0.28917131 |
| 85 | WNK1 | 0.28888421 |
| 86 | EGFR | 0.28760561 |
| 87 | BCKDK | 0.26379183 |
| 88 | PDPK1 | 0.26268424 |
| 89 | PRKCI | 0.25464305 |
| 90 | FGFR2 | 0.24640849 |
| 91 | FGR | 0.24435908 |
| 92 | MAPK3 | 0.21970545 |
| 93 | EPHA3 | 0.21865159 |
| 94 | MAP3K8 | 0.21566796 |
| 95 | CSNK1A1L | 0.20863472 |
| 96 | TTN | 0.20038128 |
| 97 | STK24 | 0.19770378 |
| 98 | PKN1 | 0.19278253 |
| 99 | MAPKAPK2 | 0.14731496 |
| 100 | RPS6KB2 | 0.14417132 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 7.87100961 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.69777620 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 4.50340863 |
| 4 | Asthma_Homo sapiens_hsa05310 | 2.69367045 |
| 5 | Protein export_Homo sapiens_hsa03060 | 2.51372220 |
| 6 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.39442518 |
| 7 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.34468054 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.18180340 |
| 9 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.09937397 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.05652594 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 2.04654651 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 2.03449779 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.85063829 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.76035545 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.55163400 |
| 16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.53014068 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.44958008 |
| 18 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.34865967 |
| 19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.29739461 |
| 20 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.24119198 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.20161021 |
| 22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.15243942 |
| 23 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.14727846 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.13627066 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.07829641 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.07047746 |
| 27 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.06073636 |
| 28 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.99936386 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.96332559 |
| 30 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.92798290 |
| 31 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.89355096 |
| 32 | Pertussis_Homo sapiens_hsa05133 | 0.87410478 |
| 33 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.86992375 |
| 34 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.85535649 |
| 35 | Hepatitis B_Homo sapiens_hsa05161 | 0.85008054 |
| 36 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.82207977 |
| 37 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.81000177 |
| 38 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.80707339 |
| 39 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.78442242 |
| 40 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.77084694 |
| 41 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.71467663 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 0.70501146 |
| 43 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.69766288 |
| 44 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.68826373 |
| 45 | Viral myocarditis_Homo sapiens_hsa05416 | 0.66862314 |
| 46 | Platelet activation_Homo sapiens_hsa04611 | 0.66439113 |
| 47 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.66402644 |
| 48 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.66008362 |
| 49 | Long-term potentiation_Homo sapiens_hsa04720 | 0.64379051 |
| 50 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.62905586 |
| 51 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62805175 |
| 52 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.61536401 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.60587730 |
| 54 | Insulin resistance_Homo sapiens_hsa04931 | 0.60548427 |
| 55 | Influenza A_Homo sapiens_hsa05164 | 0.60071562 |
| 56 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.60066382 |
| 57 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.58118859 |
| 58 | Other glycan degradation_Homo sapiens_hsa00511 | 0.57388626 |
| 59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56660762 |
| 60 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56132865 |
| 61 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.50673518 |
| 62 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.49084157 |
| 63 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48750846 |
| 64 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.48708349 |
| 65 | HTLV-I infection_Homo sapiens_hsa05166 | 0.44476375 |
| 66 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.43631216 |
| 67 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.42745840 |
| 68 | Shigellosis_Homo sapiens_hsa05131 | 0.41313369 |
| 69 | Hepatitis C_Homo sapiens_hsa05160 | 0.41109082 |
| 70 | Legionellosis_Homo sapiens_hsa05134 | 0.40349431 |
| 71 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38767212 |
| 72 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.38551595 |
| 73 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36990721 |
| 74 | Base excision repair_Homo sapiens_hsa03410 | 0.36668613 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.36047880 |
| 76 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.34881824 |
| 77 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34346445 |
| 78 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.33311962 |
| 79 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.33285667 |
| 80 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30723494 |
| 81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30625531 |
| 82 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.30417442 |
| 83 | Renin secretion_Homo sapiens_hsa04924 | 0.30335108 |
| 84 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.29408328 |
| 85 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.28454236 |
| 86 | Glioma_Homo sapiens_hsa05214 | 0.28387156 |
| 87 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.27157890 |
| 88 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.26466751 |
| 89 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.23927705 |
| 90 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.20072784 |
| 91 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.19919754 |
| 92 | Lysine degradation_Homo sapiens_hsa00310 | 0.18869409 |
| 93 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.18330212 |
| 94 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.17901650 |
| 95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.17564206 |
| 96 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.17229829 |
| 97 | Prostate cancer_Homo sapiens_hsa05215 | 0.17137800 |
| 98 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.15729054 |
| 99 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.15445926 |
| 100 | Cocaine addiction_Homo sapiens_hsa05030 | 0.14599709 |

